[Gefitinib-induced perforating dermatosis]

Autor:	Montse, Fernández-Guarino, Isabel, Aldanondo, Carmen, González-García, Pilar, Garrido, Ainhoa, Marquet, Bibiana, Pérez-García, Pedro, Jaén
Rok vydání:	2006
Předmět:	Male Lung Neoplasms Antineoplastic Agents Gefitinib Middle Aged Combined Modality Therapy Neoplasm Proteins ErbB Receptors Chemotherapy Adjuvant Skin Ulcer Carcinoma Squamous Cell Quinazolines Humans Drug Eruptions Pneumonectomy Protein Kinase Inhibitors
Zdroj:	Actas dermo-sifiliograficas. 97(3)
ISSN:	0001-7310
Popis:	Gefitinib (Iressa) is a new antineoplastic agent that acts by selectively inhibiting epidermal growth factor receptor tyrosine kinase (EGFR-TK). It has shown activity against several solid tumors. Because of their action mechanism, gefitinib and other tyrosine kinase inhibitors have been associated with multiple cutaneous effects, most of which are mild and well tolerated. We present a case of perforating dermatosis after treatment with gefitinib.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::d5d9faaee8ce35b07d8d809f5e83a9a7 https://pubmed.ncbi.nlm.nih.gov/16796971 Zobrazit plný text záznamu Full Text from ScienceDirect